BB CLEAR
BB CLEAR, licence 80061284: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Vichy Canada
- NPN or DIN-HM
- 80061284
- Status
- Inactive licence
- Licence date
- 28 May 2015
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 2.0 Pour cent | Not calculated |
Non-medicinal ingredients
C.I. 77499, Palmitate d'ascorbyle, Glycérine, Tocophérols, Diméthicone, Gluconate de zinc, Silylate de silice, PEG-10 diméthicone, Phénoxyéthanol, Dipropylène glycol, Hydroxyde d'aluminium, Déshydroacétate de sodium, Parfum, PEG-9 Polydiméthylsiloxy éthyl diméthicone, Malate de diisostéaryle, Isododécane, C.I. n° 77891, Aqua, Chlorphénésine, Hydroxyde de sodium, C.I. 77491, Copolymère d'acrylates, Stéaroyl glutamate de disodium, PEG-9, Kaolin, Hectorite de distéardimonium, Chlorure de sodium, Polymère croisé de Diméthicone/Polyglycérine-3, C.I. 77492
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | 1.0 Crème | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Helps treat and prevent acne pimples.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Using other topical acne products at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one product should be used unless directed by a doctor. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. Discontinue use if excessive skin irritation develops or increases. If irritation persists, consult a doctor.
Source
Official Health Canada record, licence 80061284
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.